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Abstract
Background—Few community-based clinicians have been trained to deliver contingency
management (CM) treatments, and little data exist regarding the efficacy of CM when
administered by clinicians.
Method—Fifteen clinicians from four intensive outpatient treatment programs received training
in CM. Following a didactics seminar and a period in which clinicians delivered CM to pilot
patients while receiving weekly supervision, clinicians treated 43 patients randomized to standard
care or CM, without supervision. In both treatment conditions, urine and breath samples were
collected up to twice weekly for 12 weeks, and CM patients earned the opportunity to win prizes
ranging in value from $1 to $100 for submitting drug-free samples. Primary treatment outcomes
were sessions attended, unexcused absences, longest continuous period of abstinence, and
proportion of negative samples submitted.
Results—All therapists completed the training and supervision phase, and 10 treated randomized
patients. Patients randomized to CM achieved significantly greater durations of abstinence than
patients randomized to standard care (5.0 ± 3.8 versus 2.6 ± 3.7 weeks) and had fewer unexcused
absences (4.3 ± 1.2 versus 8.1 ± 5.4), but proportion of negative samples submitted and attendance
did not differ significantly between groups. Therapist adherence and competence in CM delivery
decreased when supervision was no longer provided, and competence in CM delivery was
associated with duration of abstinence achieved and attendance.
Conclusions—Community-based clinicians can effectively administer CM, and outcomes relate
to competence in CM delivery. These data call for further training and supervision of community
clinicians in this evidence-based treatment.
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1. Introduction
Contingency management (CM) treatments are highly efficacious in improving substance
abuse treatment outcomes (Dutra et al., 2008; Lussier et al., 2006; Prendergast et al., 2006).
However, CM interventions demonstrated efficacious in research studies are rarely utilized
in practice (McGovern et al., 2004), and even in studies in which CM was examined in
community-based clinics, therapists working at the sites usually did not administer the
treatment. For example, the National Institute on Drug Abuse’s Clinical Trials Network
(CTN) studies (Peirce et al., 2006; Petry et al., 2005a) examined the efficacy of CM in over
800 stimulant abusing patients from 14 community clinics. Patients were randomized to
standard care plus breath and urine testing or that same treatment plus the chance to win
prizes contingent upon abstinence. In outpatient drug-free settings (Petry et al., 2005a), the
mean (standard deviation; SD) duration of abstinence increased from 5.2 (6.9) weeks in
standard care to 8.6 (9.2) weeks with CM. Although CM was efficacious across community
clinics, research assistants, not clinic counselors, administered the CM.
With the publication of these positive results, clinicians have begun using CM in some
community-based clinics (Henggeler et al., 2007, 2008; Kellogg et al., 2005; Ledgerwood et
al., 2008; Lott and Jencius, 2009; Squires et al., 2008). However, implementation may not
be optimal without appropriate understanding of CM principles and sufficient training
experiences. Training in an evidence–based treatment involves didactics, observation, and
practice, with supervision by individuals experienced in the intervention (Sholomskas et al.,
2005). Supervision usually addresses both adherence and competence in therapy delivery.
Adherence refers to integrity of the therapy, and competence refers to the quality or skill
with which interventions are delivered. In one of the few studies examining adherence to
CM principles, Andrzejewski et al. (2001) noted that without regular supervision, clinicians’
administration of CM was suboptimal, and clinicians often failed to monitor and reinforce
behaviors according to CM principles. Competence is also important in therapy delivery and
has been associated with patient outcomes generally (Barber et al., 1996; Martino et al.,
2008). Thus, adherence and competence in CM delivery is needed before widespread
implementation, and once clinicians are trained to adhere to CM principles and administer
CM competently, it is necessary to ascertain if patients improve in areas that are clinically
important.
This study describes a training program in CM that was administered to clinicians in four
outpatient, non-methadone clinics. It also describes outcomes from a randomized trial
conducted in these clinics. Inclusion criteria were broad to evaluate effects of CM among
patients typically seen in these settings. We expected that once therapists were trained to
appropriate standards, CM would enhance durations of abstinence and retention and reduce
unexcused absences, a common clinical concern (Dutra et al., 2008; McLellan et al., 2000;
Stark, 1992). We also present data on proportion of negative samples submitted, although
beneficial effects of CM on this variable are rarely observed in non-methadone settings
because these patients usually submit negative samples so long as they remain engaged in
treatment (Petry et al., 2004, 2005a,b, 2006). Results are presented for the sample overall as
well as within each clinic to ascertain variability across settings. In addition, we examined
associations between competence in CM delivery and patient outcomes, with the expectation
that more competent CM administration would be associated with better outcomes.
2. Methods
2.1. Participants
Fifteen counselors, employed at four outpatient treatment facilities in 2006 and 2007,
participated. The clinics were all not-for-profit and provided intensive outpatient treatment
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as well as continuing aftercare. Inclusion criteria for therapists were: employed at the facility
for at least 6 months, at least one year experience working with substance abusing patients,
and willingness to allow random assignment of patients. All therapists employed by the
clinics at the time of training (two to five per site) participated. Mean (standard deviation;
SD) age was 45.6 (11.5) years, and nine (60.0%) were women. Three therapists (20.0%)
were Hispanic, one (6.7%) was African American, two (13.3%) were multi-racial, one
(6.7%) was American Indian/Alaskan, and the remainder European American. One (6.7%)
had an associate’s degree, three (20.0%) bachelor’s degrees, ten (66.7%) master’s degree,
and one (6.7%) a Psy.D. Four (26.7%) reported not being in recovery from substance use,
and the remainder choose not to answer the question. They had worked with substance
abusers for a mean (SD) of 7.7 (6.6) years, and nine (60.0%) had a license to practice. None
had prior exposure to CM.
Patients were 78 (35 pilot and 43 randomized) individuals age 18 or older beginning
intensive outpatient treatment. The randomized phase had an additional inclusion criterion
of abuse or dependence on cocaine, opioids, marijuana, or alcohol. The only exclusionary
criteria were significant uncontrolled psychiatric conditions (e.g., suicidality, psychosis) and
being in recovery from pathological gambling. This latter criterion was applied because of
potential similarity between the reinforcement system and gambling, although no increases
in gambling have been reported with prize CM (Petry and Alessi, 2010; Petry et al., 2006).
The baseline assessment consisted of modules adapted from the Structured Clinical
Interview for DSM-IV (First et al., 1996) and the Addiction Severity Index (ASI) (McLellan
et al., 1985). Figure 1 shows the flow of patients in the study, and patients received $25 for
completing the baseline assessment. Pilot patients completed abbreviated assessments,
containing only information related to inclusion and exclusion criteria.
Therapist and patient participants (including pilot patients, see below) signed informed
consent for study participation, including audiotaping of interactions. University and
Hospital Institutional Review Boards approved study procedures.
2.2. Study overview
The project consisted of three components: a training phase, a supervision phase, and a
randomized phase. Each phase is outlined below.
2.2.1. In the training phase—therapists participated in two half-day trainings led by a
study author that included didactics, demonstration of alcohol and urine sample testing, and
CM practice with role plays (see below). Before and after the didactics, therapists completed
a 20-item general CM knowledge test (Petry and Stitzer, 2002). After the training, they also
completed a 20-item multiple choice test about details of this study’s CM procedures and a
training satisfaction form.
After achieving adequate scores of ≥ 16 correct on CM knowledge tests, therapists
participated in at least three CM role-plays in which they played the part of a therapist and a
research assistant assumed the role of a patient. Scenarios included: (1) describing CM to a
new patient, (2) providing reinforcement to a patient testing negative, and (3) withholding
reinforcement from a patient testing positive. Study authors and research assistants rated
audiotaped role plays using the 12-item Contingency Management Competence Scale
(CMCS; Petry et al., 2010). Ratings range from 1 (“poor”) to 7 (“excellent”), with scores of
4 or greater indicating “acceptable” quality. The CMCS contains two subscales. One relates
to Draws and reflects mean ratings on items assessing the discussion of results of sample
testing, number of draws earned that session, and number of draws possible at the next
session. The second subscale is entitled the General subscale, and it is derived from mean
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ratings on all other items. Interrater reliability, derived from three independent raters, was
0.92. Internal consistency and descriptive, concurrent and predictive validity of the CMCS
are good to excellent (Petry et al., 2010). After therapists achieved mean ratings of “4” or
higher on all CMCS items on three role plays, they proceeded to a CM supervision phase.
2.2.2 In the supervision phase—therapists delivered CM as described below to 2–3
pilot patients. A 10-item CM checklist rated adherence and included items about urine and
breath sample and draw outcomes as recorded on paper forms (Petry, 2011). Scores ranged
from 0 (none) to 10 (perfect) adherence. For example, if a therapist failed to write down
results from the toxicology test, the number of draws earned, or the types of prizes won, or
the draws earned or prizes won were inconsistent with the reinforcement schedule (see
treatment section), a lower score would be given. During weekly supervision, CM experts
discussed checklists with therapists.
To evaluate competence in CM, CM sessions were audiotaped and rated via the CMCS.
During the supervision phase, research staff provided graphical feedback of CMCS scores
weekly. Audiotapes of CM were also reviewed in supervision to point out particularly good,
and incorrect, CM administration. After therapists received ratings on the CMCS of “4” or
higher for at least three sessions in a row with two pilot patients, they proceeded to the
randomized phase.
2.2.3. In the randomized phase—research assistants randomized patients (N = 43) to
standard care or standard care plus CM using a computerized urn program (Stout et al.,
1994) that balanced groups on therapist and baseline toxicology results. Therapists
audiorecorded discussions regarding sample testing in both conditions. Research staff
monitored therapists’ delivery of CM using the CMCS and adherence checklist, but they
provided no feedback to therapists in this phase. Blinding individuals to treatments was not
possible due to the nature of the intervention.
2.3. Treatments
Standard care (SC) was similar across clinics, and included one to four group sessions per
day, three to four days a week, during the first four weeks. After four weeks of intensive
treatment, care tapered to a minimum of one group session per week. Sessions addressed
relapse prevention, coping and life skills training, depression, anxiety, and drug use, AIDS
education, and daily planning. In addition to standard care, study patients submitted breath
and urine samples twice weekly (e.g., Monday-Thursday, Monday-Friday, Tuesday-Friday)
that were screened for alcohol using an Intoximeter (St. Louis, Mo) and for cocaine, opioids
and marijuana using onsite Teststicks (Varian, Palo Alto, CA). Sample submission was
observed by a same-gender staff member when possible (e.g., study therapist or another
therapist if the study therapist was not the same gender as the patient). Samples were
collected before or after group therapy sessions, at times mutually convenient to both
parties. Therapists were asked to congratulate patients when they tested negative and discuss
positive samples as they normally would, encouraging abstinence.
Contingency management consisted of the same treatment as SC, including sample testing.
Patients in this condition (in both the supervision and randomized phases) also earned the
chance to win prizes for submitting negative samples. Each day they provided a breath
sample negative for alcohol (<.003 g/dl) and a urine sample negative for cocaine, opioids,
and marijuana they earned at least one draw from an urn, each of which provided the chance
of winning a prize. Number of draws increased by one for each consecutive set of negative
samples submitted, such that the second consecutive day samples tested negative resulted in
two draws, the third three draws, and so on up to a maximum of 10 draws per day. Patients
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could earn up to 195 draws if they submitted all negative specimens throughout the 12-week
study period.
If patients submitted a sample positive for one of the substances, refused a sample, or had an
unexcused absence on a testing day (excused absences included court appearance and
medical appointments), they received no draws that day. The next negative sample resulted
in one draw. Draws remained low (but still escalated by one for each consecutive negative
sample) until three consecutive negative samples were submitted, and then draws returned to
the highest level of draws that patient had previously achieved (see also Higgins et al.,
2000).
Patients drew from an urn containing 500 cards. Half the cards were not associated with a
prize and stated “Good job!” The other half were winning cards: 216 were small $1 prizes
(e.g., choice of bus tokens, $1 fast food coupons, toiletries); 33 were large prizes worth up to
$20 (e.g., choice of movie theater tickets, CDs, phone cards, watches); and one was a jumbo
prize worth up to $100 (e.g., choice of stereo or television). Average expected cost per draw
was about $1.95. Research staff purchased prizes, but clinic therapists completed all other
aspects of CM, including screening samples and calculating and administering draws and
prizes.
2.4. Data analysis
Descriptive data are presented in terms of how therapists met the training criteria, along with
their responses to a questionnaire regarding satisfaction with the CM training. Paired t-tests
compared therapists’ scores pre- and post-training on the CM knowledge test.
For patients in the randomized phase, chi-square and t-tests compared baseline
characteristics between patients randomized to the two conditions. Primary outcomes were:
sessions attended, number of unexcused absences on urine testing days, longest duration of
abstinence, and proportion of samples that tested negative. Proportion of negative samples
was calculated with number of samples submitted in the denominator; the mean (SD)
number of samples submitted did not differ by condition, SC = 10.0 (5.4) and CM = 12.7
(6.6), t(41) = 1.47, p = .15. A week of abstinence was defined as two consecutively
scheduled samples that tested negative for alcohol, cocaine, opioids, and marijuana. If a
patient did not attend a scheduled session or refused to provide or missed a sample because
of an unexcused absence, the string of abstinence was broken. Consistent with the
reinforcement schedule, excused absences (mean <1/patient) did not break an abstinence
string if they were preceded and followed by negative samples. Multivariate analysis of
variance (MANOVA) evaluated group differences, with the four primary outcomes as
dependent variables. Treatment condition and clinic were independent variables (therapist
could not be used as an independent variable in these analyses because one therapist treated
only one randomized patient, but all clinics had patients randomized to both conditions).
Initially, the interaction between treatment condition and clinic was included in the model,
but because the interaction was not significant (ps > .46) it was excluded. Results are
presented for the sample overall, and within each clinic means and standard deviations are
presented. Statistical testing was not conducted within clinics due to the small sample sizes,
which were not expected to yield significant difference between groups.
We also compared adherence and competence in CM delivery in the supervision phase to
the randomized phase, when no supervision was provided. Univariate ANOVA evaluated
differences between the two phases in adherence checklist scores and MANOVA for CMCS
subscale scores. In both analyses, therapist and phase (supervision or randomized) were
included as independent variables, using only data from therapists who participated in both
phases. Finally, we evaluated whether competence in CM delivery during the randomized
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phase was related to patient outcomes. For patients assigned to CM, MANOVA examined
predictors of the four outcomes, with therapist and CMCS subscale scores, derived from
mean ratings of all sessions for each patient, as independent variables. Analyses were
conducted on SPSS (v 15), with p < .05 considered significant.
3. Results
3.1. Therapist training
All 15 therapists completed didactics training. Mean (SD) correct scores on the CM
knowledge test pre-training were 12.7 (2.5) of 20, and they rose post-training to 17.7 (1.8), t
(14) = 8.61, p < .001. On the CM protocol test, therapists answered 18.8 (1.2) of 20
questions correctly. Mean (SD) scores on role plays were 6.6 (0.6) for the Draw subscale
and 6.1 (0.6) for the General subscale, indicating “very good” competence in CM delivery.
Fourteen therapists completed training evaluations (Table 1), with all therapists rating the
training from “Above Average” to “One of the Best”.
In the supervision phase, 15 therapists treated a mean (SD) of 2.5 (0.8) pilot patients.
Demographic characteristics of pilot patients are shown in the left column of Table 2. On
average, therapists required 3.8 (2.2) weeks of supervision (range 3–11 weeks) to meet
competence criteria, and on average (SD) supervision was provided for a total of 18.2 (12.8)
CM sessions. Scores on the adherence checklist, while high during therapists’ first three CM
sessions with a mean (SD) of 9.5 (0.9) out of 10 [range 7 to 10], rose significantly to 9.9
(0.3) [range 9 to 10] during the last three CM sessions of the supervision phase, t (82) =
2.79, p = .007. Scores on the CMCS subscales were also high during the first three sessions
of CM administration and remained high at the end of the supervision period, with
respective means (SD) on the Draw subscale of 6.4 (1.2) and 6.6 (0.7), and means on the
General subscale of 5.8 (1.0) to 6.1 (0.6), ps > .20. Scores on two items rose significantly.
Compared to the initial sessions of CM administration, scores at the end of the supervision
phase rose from 5.8 (1.2) to 6.5 (0.7), t (75) = 3.41, p < .001, on the praise effort item, and
from 6.2 (1.0) to 6.6 (0.5), t (75) = 2.24, p = .03, on the maintaining session structure item.
All 15 therapists completed the supervision phase, but only 10 (66.7%) proceeded to the
randomized phase. Those who discontinued participation cited time difficulties associated
with meeting patients for sample collection as the reason.
3.2. Randomized phase
Ten therapists treated 43 patients (range 1–13) randomized to SC or CM. Baseline
characteristics did not differ between patients assigned to the two conditions (Table 2). In
the MANOVA of treatment outcomes, clinic (and the clinic by treatment interaction) was
not significant (ps > .40). However, patients randomized to CM had significantly fewer
unexcused absences and achieved significantly longer durations of abstinence than those
assigned to SC. Means (SD) outcomes for patients overall and in each clinic are presented in
Table 3, along with effect sizes comparing CM to SC for the full sample.
3.2.1. Therapist performance in CM delivery during the randomized phase—
Research staff provided therapists with no feedback about CM administration during the
randomized phase. On CM adherence checklists, mean (SD) score was 9.2 (1.2) during the
randomized phase, which while high, was significantly lower than ratings obtained
throughout the supervision phase of 9.6 (0.7), F (1,572) = 7.75, p = .006. Similarly,
competence in CM administration decreased significantly on the CMCS Draw subscale, F
(6, 303) = 6.51, p = .01, and General subscale, F (6, 303) = 17.23, p < .001. Throughout the
supervision phase, mean (SD) scores on the Draw and General subscales were 6.7 (0.6) and
5.9 (0.8), respectively. In the randomized phase, scores dropped to 6.4 (0.9) and 5.4 (1.0) on
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the two respective subscales. Scores on individual items of the CMCS in the supervision and
randomized phase are shown in Table 4, and many were significantly lower during the
randomized phase. Although therapists’ overall average CMSC scores across all CM
sessions during the randomized phase remained at an acceptable level, five of 10 (50%)
therapists treated one or more CM patients less than adequately in the randomized phase,
with scores < 4.
In examining predictors of patient outcomes, scores on the CMCS Draw subscale were
significantly and positively associated with number of sessions attended and longest
duration of abstinence achieved, F (1,11) = 7.35, p = .02 and F (1,11) = 4.89, p = .04,
respectively. Scores on the CMCS General subscale were not related to outcomes, all ps >.
37.
3.2.2. Session duration, reinforcement earned, and adverse events—The mean
(SD) duration of a CM session, including awarding of prizes, was 6.0 (3.5) minutes. Patients
randomized to CM earned a mean (SD) of 70.5 (63.5) draws, resulting in 32.5 (28.9) small,
4.9 (5.7) large, and 0.2 (0.5) jumbo prizes, with an overall cost of $148.0 ($155.2) per
patient. There were no study related adverse events or increases in gambling reported.
4. Discussion
This study found that therapists can readily be trained to administer CM with a high level of
adherence and competence, and when they deliver CM to patients in outpatient substance
abuse treatment facilities, some outcomes are improved relative to standard care. Although
positive effects of CM were noted in the randomized phase, competence in CM delivery
decreased when research staff no longer provided CM supervision, and levels of competence
in delivering CM, especially in regards to discussing outcomes of sample testing and draws,
were significantly related to patient outcomes. Findings from this study underscore the need
for appropriate training and supervision in CM delivery, but they also point to potentially
strong beneficial effects associated with using CM in practice.
Regarding the first of these findings, all 15 therapists who participated in the training
showed improvements in knowledge about CM, and the training experience was rated
favorably on all indices. Few therapists endorsed any conflict between CM principles and
their beliefs about effective treatment for substance use. During role plays, therapists readily
achieved high levels of competence in CM delivery. Therapists’ adherence to the CM
protocol in terms of tracking sample results and number of draws was high following the
didactics and at the beginning of the supervision phase, and it rose to near perfect levels
within an average of 3.8 weeks of individual supervision. Likewise, competence in CM
delivery was very good at the beginning of the supervision phase, and increases in
competence were observed on two items of the CMCS during the supervision phase.
Together, these data demonstrate that this training program was well received and
successful, but this study did not compare different training approaches, and other training
procedures may also be effective.
With the training approach outlined herein, some beneficial effects of CM were noted when
patients were randomized to CM versus standard care. Specifically, CM reduced unexcused
absences and enhanced durations of abstinence. However, CM did not affect treatment
attendance in this study, and in outpatient clinics, CM usually, although not always (Petry et
al., 2004), has effects on increasing retention (Petry et al., 2000, 2006, 2005a). The effect
size for improving attendance was in the small to medium range, and it did not reach
statistical significance with this sample size. Similarly, effects of CM on reducing
proportion of negative samples were not significant, and in the small to medium range.
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Three of the four clinics showed numerical improvements in both these indices, but one
clinic did not; in both of these cases, the clinic with the best outcomes for standard care
patients showed no numerical improvements with CM. Similarly, for the two variables in
which overall effects of CM were significant, large variations across clinics were observed,
with CM seemingly exerting the most benefits when patient outcomes during standard care
were relatively poor (i.e., high rates of unexcused absences and low durations of abstinence).
Thus, CM may be best suited for outpatient clinics and populations in which outcomes in
usual care are poor. Clinicians who implement CM in these settings may observe robust
improvements with CM.
Although CM engendered some benefits in the randomized phase, therapists’ adherence and
competence decreased when they no longer received supervision. Reductions with respect to
both monitoring (adherence checklist scores) and delivering CM (CMCS scores) were noted
in the randomized relative to supervision phase. Although reductions were minor in
magnitude and all therapists retained “adequate” average levels of CM delivery overall, five
therapists treated one or more CM patients at below adequate levels of competence, and
several of the differences in CMCS scores between the phases were statistically significant.
Because competence in CM delivery as measured on the Draws subscale was related to
some patient outcomes, these data suggest that more sustained supervision than that
provided in the context of this project may be necessary to ensure high rates of appropriate
CM delivery to optimize patient outcomes.
These results should be interpreted in the context of some limitations. This study was
conducted with clinicians working in intensive outpatient clinics, and these results may not
generalize to other therapists and settings. These therapists were highly educated, which
may have made them more willing to implement CM. As noted previously, we did not
evaluate the efficacy of training and supervision methods, and the training, while brief in
duration, was individualized. Although therapists continued administering CM adequately
after the supervision phase ended, competence and adherence declined significantly on some
measures, implying that a longer supervision phase or perhaps booster supervision may be
needed to optimize benefits. Psychometric properties of the 10-item adherence checklist
have not been formally evaluated, but the CMCS has demonstrated reliability and validity
(Petry et al., 2010). Another limitation is that the number of patients in the randomized
phase was small, and most therapists treated only a few patients. Finally, one-third of the
clinicians choose not to participate in the randomized phase due to time constraints
associated with meeting with patients for sample testing, and none of the clinics
implemented CM after the study ended. This study provided financial resources and
administrative oversight for the prizes, and management of prizes adds further to the
administrative costs of CM (Olmstead et al., 2007; Petry, 2011). More work is needed to
address issues related to sustainability of CM.
Strengths of this study are that it employed a randomized design in four community-based
clinics, and 15 therapists participated. When provided with appropriate CM protocols and
training experiences, community-based clinicians were able to implement CM effectively.
Importantly, patients who were randomized to the CM condition showed improvements in
clinically important domains. Given the high rates of attrition from treatment and relapse in
substance abusing patients (Dutra et al., 2008; McLellan et al., 2000; Stark, 1992), further
dissemination of CM and appropriate training and supervision in this evidence-based
practice is needed.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Flowchart of participants.
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Table 1
Therapists’ (N = 14) Ratings on Training Experiences in Contingency Management
Item % (n)
endorsing
How does this training rate to others you’ve received?
   Below average 0.0 (0)
   Average 0.0 (0)
   Above average 28.6 (4)
   Very good 35.7 (5)
   One of the best 35.7 (5)
Would you recommend this training to others?
   No, definitely not 0.0 (0)
   No, I don’t think so 0.0 (0)
   Yes, I think so 14.3 (2)
   Yes 7.1 (1)
   Yes, enthusiastically 78.6 (11)
How did this training’s materials relate to others?
   Much worse 0.0 (0)
   About the same 0.0 (0)
   Somewhat better 7.1 (1)
   Better 64.3 (9)
   Much better 28.6 (4)
How often do you think contingency management will be helpful with your
clients?
   Never 0.0 (0)
   Rarely 0.0 (0)
   Sometimes 0.0 (0)
   Often 50.0 (7)
   Very often 50.0 (7)
How much conflict do you feel there is between contingency management and
your belief about what is effective treatment for substance use?
   Extreme 0.0 (0)
   Considerable 0.0 (0)
   Moderate 0.0 (0)
   Slight 21.4 (3)
   None 78.6 (11)
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Table 3
Attendance and Abstinence Outcomes
Variable
Standard
care
Contingency
management
Statistical test
Value (df), p-value
Effect size
Cohen’s d
N 23 20
Sessions attended 10.3 ± 6.4 13.0 ± 6.5 F (1,38) = 1.97, p = .17 0.42
   Clinic A 7.8 ± 4.1 12.0 ± 6.7
   Clinic B 10.8 ± 6.4 15.5 ± 4.9
   Clinic C 9.0 ± 4.4 14.0 ± 6.7
   Clinic D 12.5 ± 7.0 11.3 ± 8.0
Unexcused absences 8.1 ± 5.3 4.3 ± 1.2 F (1,38) = 5.62, p = .02 0.71
   Clinic A 12.0 ± 8.0 6.0 ± 5.1
   Clinic B 8.8 ± 5.3 4.0 ± 4.2
   Clinic C 9.2 ± 4.6 3.7 ± 5.0
   Clinic D 3.3 ± 3.7 3.1 ± 3.9
Longest duration of abstinence 2.6 ± 3.7 5.0 ± 3.8 F (1,38) = 4.22, p = .04 0.62
   Clinic A 1.8 ± 1.2 4.3 ± 3.0
   Clinic B 3.0 ± 2.4 4.5 ± 2.1
   Clinic C 0.8 ± 0.8 5.8 ± 3.9
   Clinic D 4.5 ± 4.7 4.8 ± 5.6
% Submitted samples negative 80.5 ± 28.8 89.6 ± 29.5 F (1,38) = 1.10, p = .30 0.31
   Clinic A 77.8 ± 40.4 90.9 ± 20.1
   Clinic B 88.5 ± 10.4 80.7 ± 19.8
   Clinic C 69.9 ± 43.2 92.8 ± 13.4
   Clinic D 85.3 ± 25.7 86.7 ± 32.6
Note. Values represent means and standard deviations.
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Table 4
Mean Ratings on Items from the Contingency Management Competence Scale
CM tapes
(n = 171)
supervision
phase
CM tapes
(n = 148)
randomized
phase
Statistical test
(df), p
Item or scale
1. To what extent did the therapist discuss
outcomes of urine and breath sample
monitoring?
6.9 ± 0.4 6.4 ± 0.9 t (317) = 5.91,
p < .001
2. To what extent did the therapist state how
many draws were earned at this session?
6.8 ± 0.9 6.6 ± 1.2 t (317) = 2.16,
p = .03
3. To what extent did the therapist state how
many draws would be earned at the next
session if the client were abstinent?
6.5 ± 1.5 6.1 ± 2.0 t (304) = 1.95,
p = .05
4. To what extent did the therapist assess the
client’s desire for items in the prize cabinet?
5.4 ± 1.6 5.4 ± 1.9 t (314) = 0.17,
p = .86
5. To what extent did the therapist discuss the
client’s self-report of substance use?
6.0 ± 1.1 4.5 ± 1.0 t (17) = 2.70,
p = .02
6. If the client self-reported substance use, to
what extent did the therapist relate self-reports
of substance use to objective indicators of
substance use?
6.4 ± 0.8 5.7 ± 2.4 t (16) = 1.00,
p = .33
7. If the client self-reported substance use, to
what extent did the therapist relate self-report
of substance use to consequences of positive
samples?
6.0 ± 1.3 5.5 ± 1.5 t (17) = 0.72,
p = .48
8. To what extent did the therapist
compliment/praise client’s efforts toward
abstinence?
6.3 ± 0.9 5.5 ± 1.1 t (309) = 7.46,
p < .001
9. To what extent did the therapist
communicate confidence that the client’s
efforts will yield success in the future?
5.9 ± 1.2 5.2 ± 1.3 t (307) = 5.29,
p < .001
10. General skillfulness (expertise, competence
and commitment, engages client in discussion,
interventions made at appropriate times—not
missed or made too early).
6.1 ± 0.8 5.5 ± 1.1 t (310) = 5.36,
p < .001
11. Maintaining session structure (maintains
session focus, sets appropriate tone and
structure, appropriate level of therapist
activity/directiveness, duration).
6.5 ± 0.7 5.7 ± 1.0 t (310) = 8.69,
p < .001
12. Empathy (conveys warmth and sensitivity,
demonstrates genuine concern and a non-
judgmental stance, understands/expresses
clients’ feelings and concerns).
6.6 ± 0.7 5.9 ± 1.0 t (310) = 7.26,
p < .001
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